ebomi
Colour theme
Sign in
Insider · CIK 0001528185

Torley Helen

CIK 0001528185 Name as filed on the most recent filing

Filed as Torley Helen (50)

186 transaction lines · from 50 filings · filed 2012-07-27 to 2026-08-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

186 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-08-19 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 3,200 disposed 107.76 344,848.00 Form 4, filing 0001159036-26-000108
2026-08-19 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 9,600 disposed 107.22 1,029,350.40 Form 4, filing 0001159036-26-000108
2026-08-19 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 7,200 disposed 106.36 765,777.60 Form 4, filing 0001159036-26-000108
2026-08-18 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 9,400 disposed 104.87 985,815.60 Form 4, filing 0001159036-26-000108
2026-08-18 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 4,897 disposed 104.11 509,826.67 Form 4, filing 0001159036-26-000108
2026-08-18 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 5,703 disposed 103.08 587,882.35 Form 4, filing 0001159036-26-000108
2026-08-17 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 7,500 disposed 103.48 776,115.00 Form 4, filing 0001159036-26-000108
2026-08-17 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 9,000 disposed 102.55 922,977.00 Form 4, filing 0001159036-26-000108
2026-08-17 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 2,100 disposed 101.77 213,708.60 Form 4, filing 0001159036-26-000108
2026-08-17 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 500 disposed 100.46 50,228.50 Form 4, filing 0001159036-26-000108
2026-08-17 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 900 disposed 98.96 89,062.20 Form 4, filing 0001159036-26-000108
2026-07-08 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 1,035 disposed 80.19 82,993.54 Form 4, filing 0001159036-26-000100
2026-07-08 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 888 disposed 79.28 70,397.09 Form 4, filing 0001159036-26-000100
2026-06-03 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 6,100 disposed 69.69 425,121.20 Form 4, filing 0001159036-26-000074
2026-06-03 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 2,000 disposed 68.74 137,472.00 Form 4, filing 0001159036-26-000074
2026-06-03 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 1,500 disposed 67.68 101,512.50 Form 4, filing 0001159036-26-000074
2026-06-03 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 400 disposed 66.37 26,547.20 Form 4, filing 0001159036-26-000074
2026-06-02 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 16,600 disposed 66.31 1,100,812.40 Form 4, filing 0001159036-26-000074
2026-06-02 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 3,400 disposed 66.74 226,933.00 Form 4, filing 0001159036-26-000074
2026-06-01 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 12,989 disposed 67.41 875,588.49 Form 4, filing 0001159036-26-000074
2026-06-01 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 5,401 disposed 68.35 369,136.75 Form 4, filing 0001159036-26-000074
2026-06-01 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 1,610 disposed 66.39 106,884.68 Form 4, filing 0001159036-26-000074
2026-05-13 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 3,950 disposed 69.79 275,658.65 Form 4, filing 0001159036-26-000070
2026-05-13 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 3,350 disposed 68.88 230,748.00 Form 4, filing 0001159036-26-000070
2026-05-13 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 2,100 disposed 68.10 143,014.20 Form 4, filing 0001159036-26-000070
2026-05-13 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 600 disposed 70.81 42,487.20 Form 4, filing 0001159036-26-000070
2026-05-12 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 9,802 disposed 71.37 699,568.74 Form 4, filing 0001159036-26-000070
2026-05-12 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 5,900 disposed 72.15 425,673.20 Form 4, filing 0001159036-26-000070
2026-05-12 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 2,800 disposed 73.12 204,738.80 Form 4, filing 0001159036-26-000070
2026-05-12 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 1,398 disposed 70.29 98,261.23 Form 4, filing 0001159036-26-000070
2026-05-12 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 100 disposed 67.85 6,785.00 Form 4, filing 0001159036-26-000070
2026-05-11 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 9,725 disposed 64.63 628,536.48 Form 4, filing 0001159036-26-000070
2026-05-11 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 6,700 disposed 66.33 444,390.90 Form 4, filing 0001159036-26-000070
2026-05-11 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 3,575 disposed 65.46 234,012.35 Form 4, filing 0001159036-26-000070
2026-04-06 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 5,900 disposed 63.14 372,520.10 Form 4, filing 0001159036-26-000048
2026-04-06 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 4,100 disposed 64.02 262,461.50 Form 4, filing 0001159036-26-000048
2026-04-02 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 15,800 disposed 64.06 1,012,195.40 Form 4, filing 0001159036-26-000046
2026-04-02 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 4,200 disposed 64.89 272,525.40 Form 4, filing 0001159036-26-000046
2026-04-01 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 19,000 disposed 65.36 1,241,802.00 Form 4, filing 0001159036-26-000046
2026-04-01 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 1,000 disposed 65.71 65,714.00 Form 4, filing 0001159036-26-000046
2026-03-04 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 7,329 disposed 69.94 512,619.58 Form 4, filing 0001159036-26-000032
2026-03-04 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 2,671 disposed 70.94 189,494.10 Form 4, filing 0001159036-26-000032
2026-03-03 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 13,481 disposed 68.85 928,166.85 Form 4, filing 0001159036-26-000032
2026-03-03 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 6,519 disposed 69.33 451,981.83 Form 4, filing 0001159036-26-000032
2026-03-02 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 15,322 disposed 69.80 1,069,460.28 Form 4, filing 0001159036-26-000032
2026-03-02 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 4,100 disposed 69.20 283,707.70 Form 4, filing 0001159036-26-000032
2026-03-02 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 578 disposed 70.46 40,726.46 Form 4, filing 0001159036-26-000032
2026-02-05 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 5,376 disposed 78.38 421,365.50 Form 4, filing 0001159036-26-000012
2026-02-05 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 4,624 disposed 78.94 365,000.06 Form 4, filing 0001159036-26-000012
2026-02-04 Halozyme Therapeutics, Inc.
HALO 		S, Open-market sale 10,100 disposed 77.54 783,154.00 Form 4, filing 0001159036-26-000012

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 185
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Torley Helen, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001528185

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.